|
Name |
3β-O-cis-p-coumaroyl-2α-hydroxy-urs-12-en-28-oic acid
|
Molecular Formula | C32H40O6 | |
IUPAC Name* |
11-hydroxy-10-[3-(4-hydroxyphenyl)prop-2-enoyloxy]-2,3,4,5,6,6a,6a,6b,7,8,8a,9,10,11,12,12a,13,14b-octadecahydro-1H-picene-4a-carboxylicacid
|
|
SMILES |
O=C(C=Cc1ccc(O)cc1)OC1CC2CCC3C4CCC5(C(=O)O)CCCCC5C4=CCC3C2CC1O
|
|
InChI |
InChI=1S/C32H40O6/c33-21-8-4-19(5-9-21)6-13-30(35)38-29-17-20-7-10-22-23(26(20)18-28(29)34)11-12-25-24(22)14-16-32(31(36)37)15-2-1-3-27(25)32/h4-6,8-9,12-13,20,22-24,26-29,33-34H,1-3,7,10-11,14-18H2,(H,36,37)/b13-6-
|
|
InChIKey |
KIXCVUNIUPFFMJ-MLPAPPSSSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 520.67 | ALogp: | 5.7 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 104.1 | Aromatic Rings: | 6 |
Heavy Atoms: | 38 | QED Weighted: | 0.261 |
Caco-2 Permeability: | -5.303 | MDCK Permeability: | 0.00000337 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.77 | 20% Bioavailability (F20%): | 0.997 |
30% Bioavailability (F30%): | 0.996 |
Blood-Brain-Barrier Penetration (BBB): | 0.162 | Plasma Protein Binding (PPB): | 98.94% |
Volume Distribution (VD): | 0.767 | Fu: | 0.40% |
CYP1A2-inhibitor: | 0.064 | CYP1A2-substrate: | 0.3 |
CYP2C19-inhibitor: | 0.079 | CYP2C19-substrate: | 0.37 |
CYP2C9-inhibitor: | 0.223 | CYP2C9-substrate: | 0.982 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.485 |
CYP3A4-inhibitor: | 0.336 | CYP3A4-substrate: | 0.293 |
Clearance (CL): | 2.246 | Half-life (T1/2): | 0.07 |
hERG Blockers: | 0.193 | Human Hepatotoxicity (H-HT): | 0.215 |
Drug-inuced Liver Injury (DILI): | 0.02 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.086 | Maximum Recommended Daily Dose: | 0.884 |
Skin Sensitization: | 0.112 | Carcinogencity: | 0.225 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.919 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001543 | 0.313 | D0U0XD | 0.295 | ||||
ENC001471 | 0.313 | D0KN2M | 0.288 | ||||
ENC001917 | 0.294 | D0Z1FX | 0.254 | ||||
ENC001942 | 0.279 | D0TB8C | 0.248 | ||||
ENC001420 | 0.268 | D03DXN | 0.248 | ||||
ENC004910 | 0.256 | D08QMX | 0.248 | ||||
ENC001582 | 0.249 | D04UZT | 0.247 | ||||
ENC002216 | 0.245 | D03CEF | 0.245 | ||||
ENC005350 | 0.243 | D07VBA | 0.245 | ||||
ENC003767 | 0.242 | D02RXG | 0.235 |